GenoScreen will be present at the 29th European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) on April 13 in Amsterdam.
On March 21st, GenoScreen will participate in the "International Conference on Tuberculosis" in Brussels.
GenoScreen announced today that it has completed a €1 million fundraising campaign with private investors.
Pioneer company since 2001 in sequencing, genotyping and bioinformatics, GenoScreen provides innovative services and solutions in genomics to address the needs of academic and industrial research teams. At the forefront of genomics in France, GenoScreen develops innovation programs that fuel its technological lead and generate high-performance analytical, products and control services.
Deeplex®-MycTB, was used in a study published in The Lancet Infectious Diseases highlighting the spread of tuberculosis strains resistant to first-line antibiotics, not detected by current diagnostic tests.
Page 1 of 2